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A mutation in the gene encoding loricrin has recently
been reported in a subset of patients with Vohwinkel’s
Keratoderma manifesting an associated ichthyosiform
dermatosis. We have studied a further kindred with this
clinical phenotype. Microsatellite marker analysis was
consistent with linkage to chromosome 1q21 and direct
sequencing of loricrin identified a heterozygous mutation
with an insertion of a T residue at codon 209. This
mutation is predicted to produce a mutant protein with
a frameshift of its terminal 107 amino acids and to be 22
amino acids longer than the wild-type protein due to a
During terminal differentiation of keratinocytes thecornified envelope (CE) is deposited on the innersurface of the plasma membrane in a highly complex,multistage process involving the sequential depositionof multiple interacting components, including involuc-
rin, loricrin, and small proline-rich proteins, amongst others (Hohl,
1990; Steinert and Marekov, 1995). Many of the genes encoding
essential components of this process are localized to chromosome 1q21,
a region designated as the epidermal differentiation complex (EDC)
(Marenholz et al, 1996; Mischke et al, 1996). Despite evidence of
abnormalities of the CE in ichthyoses and other keratinizing disorders,
the first genetic disease to be attributed to an abnormality in CE
formation was autosomal recessive lamellar ichthyosis in which a
subgroup of patients were shown to have mutations in the transglut-
aminase 1 gene (Huber et al, 1995; Russel et al, 1995). More recently,
linkage was demonstrated to the EDC and subsequently a mutation in
the gene encoding loricrin was detected in a family with Keratoderma
Hereditaria Mutilans (Vohwinkel’s Keratoderma) (Maestrini et al, 1996).
This represents the first human genetic disease to be directly attributed
to a defect in a structural component of the CE, and offers novel
insights into the potential pathogenic mechanisms underlying the
disorder. An identical mutation has since been described in a further
kindred with this disorder, although the possibility of common ancestry
could not be excluded in this report (Korge et al, 1997). Vohwinkel’s
Keratoderma (VK) is a rare dominantly inherited disorder characterized
by (i) diffuse palmoplantar keratoderma with a honeycomb appearance,
(ii) variable degrees of constricting bands encircling the digits (pseudo-
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delayed termination codon. The only previously reported
mutation is a G insertion producing a frameshift after
codon 231. The novel mutation we report is likely to
have a similar functional effect on cornified envelope
formation, with disturbance of transglutaminase-medi-
ated cross-linking of envelope components, and serves
to confirm the predicted role of insertional mutations in
Vohwinkel’s Keratoderma associated with ichthyosis. Key
words: bipartite nuclear localization signals/cornified envelope/
ichthyosis. J Invest Dermatol 111:702–704, 1998
ainhum), and (iii) starfish-shaped keratoses and/or warty papules
(Vohwinkel, 1929). Other clinical features that have been reported in
a variable proportion of cases include alopecia, high tone deafness,
myopathy, spastic paraplegia, and an associated generalized ichthyosi-
form dermatosis (Wirz, 1930; Grschebin, 1936; Drummond, 1939;
Gibbs and Frank, 1966; Reddy and Gupta, 1983; Camisa and Rosssana,
1984; Camisa et al, 1988). Interestingly, the mutation in loricrin
previously reported in this disorder was demonstrated in two families
with the clinical phenotype manifesting an associated ichthyosiform
dermatosis (Maestrini et al, 1996; Korge et al, 1997). A further family
studied with VK and associated deafness but lacking ichthyosis failed
to show linkage to the EDC and had no underlying loricrin mutation
(Korge et al, 1997). Thus, there is evidence of both clinical and genetic
heterogeneity in this disorder.
To elucidate further the underlying pathogenesis of this disease we
have studied a further kindred with VK in whom an associated
ichthyosiform dermatosis was present and we report a novel mutation
in the gene encoding loricrin.
MATERIALS AND METHODS
Patients A family with VK associated with ichthyosiform dermatosis was
identified and all available family members were examined. Biopsies of affected
palmar skin and skin demonstrating ichthyosiform features were obtained for
light microscopy.
Genotyping and linkage analysis Genomic DNA was obtained from
peripheral white blood cells from all family members. Microsatellite markers
were polymerase chain reaction (PCR) amplified using γ[32P]-labeled primers,
analyzed on standard 6% sequencing gels, and visualized by autoradiography.
Two point lod scores were calculated using the MLINK program of FASTLINK
assuming autosomal dominant inheritance with complete penetrance and a zero
mutation rate.
Mutation analysis The terminal one-third of the loricrin gene coding
sequence was PCR amplified from genomic DNA of affected and unaffected
family members. This region included the site of the previously reported
mutation (Maestrini et al, 1996; Korge et al, 1997). Primers were designed from
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Figure 1. Pedigree of family with VK.
Figure 2. Clinical findings in VK. (a) Honeycomb keratoderma; (b) mild
pseudo-ainhum; (c) thickening of skin over knuckles with prominent skin
markings and associated hyperpigmentation.
the published sequence (Genbank M94077): 59-TACGGAGGCGTCT-
CTAGCGG-39 (sense), 59 -CCTGCTTCTGCTGGGTCTGG-39 (anti-sense).
PCR was performed with Amplitaq Gold and 0.4 micromolar primer concentra-
tions (96°C for 12 min followed by 35 cycles of 95°C for 1 min, 60°C for
1 min, and 72°C for 1 min, and then 72°C for 10 min). PCR products were
purified using a Wizard Kit (Promega Southampton, UK) and sequenced with
both primers using the ABI PRISM Ready Reaction system (Perkin Elmer,
Warrington, U.K.). Sequencing products were analyzed on an ABI 377
automated sequencer. The mutation detected destroys an Nla IV restriction site
in the mutant allele. To confirm the mutation in affected family members and
exclude it in unaffected family members and normal controls, PCR products
generated with the above primers were digested at 37°C for 3 h with Nla IV
(New England Biolabs, Herts, U.K.) and analyzed on 3% agarose gel.
RESULTS
Clinical features The family consisted of 15 individuals with eight
affected members (Fig 1). The clinical phenotype corresponded closely
to the variant described by Camisa and Rossana (1984). The palmo-
plantar hyperkeratosis was diffuse with a honeycomb appearance and
was noted within a few weeks of birth (Fig 2a). An erythematous
hyperkeratosis extended from the palms on to the flexor aspects of the
wrists and had a discrete proximal edge at this site. Digital constrictions
were present in all but two individuals, but were mild in all cases
(Fig 2b). There was no evidence of digital circulatory impairment or
auto-amputation. All individuals had hyperkeratosis with prominent
skin markings over the knuckles; in one individual there was notable
hyperpigmentation associated with this (Fig 2c). All affected patients had
an associated generalized nonerythematous ichthyosiform dermatosis,
present from birth, which was most prominent over the extensor
aspects of the limbs with marked hyperkeratosis over the elbows and
knees. There was no evidence of hearing impairment, alopecia, or
muscle weakness and the nails, hair, and teeth were normal.
Light microscopy Histopathology of palmar skin and an area of
ichthyosis showed similar features with moderate epidermal hyperplasia,
marked thickening of the granular layer (7–8 layers), and hyperkeratosis
with retention of rounded nuclei. The initial biopsies were performed
Figure 3. Identification of heterozygous insertion at codon 209 of
loricrin in affected individual. Automated sequencing of coding strands of
loricrin around the T insertion (arrow) at codon 209 in normal (top) and affected
(bottom) individuals.
in a nonteaching center and subsequent requests for a further biopsy
for electron microscopy were declined by the index case and her family.
Linkage to EDC at 1q21 Linkage analysis showed complete cosegre-
gation of the disease phenotype with the markers D1S306 and D1S1664,
which map to the EDC (data not shown). The maximum lod score
of 2.41 at θ 5 0 with both markers was consistent with linkage to the
EDC but not conclusive of this.
Mutation in loricrin PCR product of appropriate size was amplified
from the terminal third of the gene encoding loricrin from genomic
DNA of affected and unaffected family members. Direct sequencing
of the purified product demonstrated a heterozygous mutation with
insertion of a T residue at codon 209 in all five affected family members
sequenced and in none of five unaffected members tested (Fig 3). The
mutation was confirmed by restriction digestion of PCR product of
all affected and unaffected family members with NlaIV. The insertion
in the mutant allele results in a loss of a NlaIV cutting site with the
production of a 168 bp fragment, whereas digestion of the normal
allele produces a 150 bp fragment. The mutation was also excluded
from 100 normal control alleles.
DISCUSSION
VK is the first human genetic disease to be attributed to an abnormality
of a structural component of the CE. To date a single mutation has
been described in two families with a heterozygous G residue insertion
at an area of six consecutive G residues at codons 230–231 of loricrin.
It should be noted that both families had an associated ichthyosiform
dermatosis (Maestrini et al, 1996; Korge et al, 1997). We report a
second insertional mutation upstream in the loricrin gene with insertion
of a T residue at codon 209 in a further family with this variant of
VK. This mutation is predicted to produce a mutant protein with a
frameshift of its terminal 107 amino acids and to be 22 amino acids
longer than the normal wild-type protein due to a delayed termination
codon. The functional consequences of this mutation are predicted to
be essentially similar to those of the previously described mutation.
Loricrin consists of four glycine loop domains that are interspersed and
flanked by glutamine- and glutamine/lysine-rich regions (Hohl et al,
1991). The glycine loop domains are predicted to be highly flexible
and may function to impart flexibility and extensibility to the CE and
epidermis. In addition, it is believed that the glycine loops of loricrin
interact with similar motifs in the V1 and V2 keratin domains (Hohl
et al, 1991; Steinert et al, 1991). The glutamine- and glutamine/lysine-
rich regions, however, function as critical substrates for transglutamin-
ase-mediated Nε-(γ-glutamyl)lysine isodipeptide cross-linking of CE
components (Hohl et al, 1991; Candi et al, 1995; Steinert and Marekov,
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Figure 4. Predicted amino acid sequence of mutant loricrin at 39 end.
Comparison of mutant (Mut) and wild-type (WT) predicted amino acid
sequence after T insertion at codon 209 (arrow). The presence of a potential
nuclear targeting motif is underlined.
1995). The presence of such isodipeptide cross-links in addition to
disulfide bonds between constituent proteins accounts for the highly
insoluble nature of the CE. Although studies indicate that almost every
lysine and glutamine residue of loricrin can be identified in cross-links,
the residues Gln215, Gln216, and Lys315 appear to be particularly
functionally prominent in this process (Candi et al, 1995; Steinert et al,
1995). The novel mutation we report results in the replacement of the
fourth glycine loop domain and the C-terminal glutamine/lysine-rich
domain of the normal protein with an arginine- and leucine-rich
region in the mutant peptide. This is likely to affect the function of
the mutant peptide both by altering its flexibility and by disrupting
transglutaminase-mediated cross-linking of the peptide to other loricrin
molecules and to other components of the CE.
A recent report has also suggested that such an insertional mutation
in loricrin will result in the introduction of potential nuclear targeting
motifs in the arginine-rich sequences of the mutant C-terminal peptide
that are lacking in the normal protein (Korge et al, 1997). Indeed the
presence of such sequences may explain the presence of intranuclear
accumulations of loricrin in the granular cell layer that has been
previously well reported in this disorder (Maestrini et al, 1996; Korge
et al, 1997). Unfortunately, electron microscopic studies are not available
for this kindred. Bipartite nuclear localization signals comprise a pair
of basic amino acids, a spacer of any 10 amino acids, and then a cluster
in which three of the next five amino acids are basic (Dingwall and
Laskey, 1991; Nigg, 1997). The length of the amino acid spacer,
however, may not be critical (Dingwell and Laskey, 1991). The
previously reported G insertion resulting in a frameshift after codon
231 was noted to give rise to four bipartite nuclear localization signals
with a 10 amino acid spacer and a potential fifth signal with a 16
amino acid spacer (Korge et al, 1997). Although the novel mutation
we report has no further bipartite nuclear localization signals as defined
by a 10 amino acid spacer compared with the previously reported
mutation, a further potential sequence with a 9 amino acid spacer
begins at codon 229 in the mutant allele (Fig 4). Loricrin monomers
are known to cross-link to each other by disulfide bonds. The
intranuclear granules in this disorder have been shown to contain
normal loricrin in addition to the mutant protein, and it has been
suggested that complexing of the normal protein by the mutant type
and subsequent sequestration in the nuclear granules may produce
relative loricrin deficiency and compound further the defective CE
formation (Korge et al, 1997).
In conclusion, we report a second insertional mutation in loricrin
in a family with VK associated with ichthyosis likely to have similar
functional consequences to the previously reported mutation. The
possible presence of other types of loricrin mutation in ichthyotic
disorders or keratodermas deserves further study.
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